MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 23, 2006--Depomed, Inc. (NASDAQ:DEPO) announced today that Bret Berner, Ph.D., vice president, Product Development has additionally been appointed chief scientific officer. Dr. Berner, a highly regarded, well-published pharmaceutical drug delivery and formulations scientist, has led the company’s drug development efforts since 1998.
